Since MD‐1 is reported to deliver cardiac protection against cardiac hypertrophy and suppresses cardiac dysfunction during the remodelling process through modulating MEK‐ERK 1/2 and NF‐κB signalling pathways.19 Thus, we investigated the expression of MAPK and NF‐κB pathways in the hearts of mice models. Here, LY86 is linked to cardiac hypertrophy.